Loading company…
Ombre sells at-home microbiome tests with personalized food recommendations and probiotic formulations, based in San Francisco.
Founded in 2016 and based in California, US, Thryve, Inc., trading as Ombre, offers monthly subscription microbiome testing. Users collect a sample at home, which is analyzed by DNA sequencing, and receive personalized food recommendations and tailored probiotic formulations. In August 2024 the company raised EUR 4 million in Series A funding led by Capricorn Partners, with IBB Ventures, CRB Inverbio and CARMA FUND Management. The listed stage is Seed.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in